The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Athira Pharma Inc’s stock clocked out at $0.43, down -7.44% from its previous closing price of $0.46. In other words, the price has decreased by -$7.44 from its previous closing price. On the day, 0.73 million shares were traded. ATHA stock price reached its highest trading level at $0.4692 during the session, while it also had its lowest trading level at $0.4303.
Ratios:
To gain a deeper understanding of ATHA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.97 and its Current Ratio is at 3.97. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on September 19, 2024, Downgraded its rating to Neutral and sets its target price to $0.50 from $5 previously.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 05 ’24 when Mark James Litton bought 5,032 shares for $0.00 per share.
Gengos Andrew sold 1,272 shares of ATHA for $720 on Sep 05 ’24. The CFO and Chief Business Officer now owns 97,532 shares after completing the transaction at $0.57 per share. On Sep 05 ’24, another insider, Lenington Rachel, who serves as the COO and CDO of the company, sold 2,525 shares for $0.57 each. As a result, the insider received 1,429 and left with 20,870 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATHA now has a Market Capitalization of 16540474 and an Enterprise Value of -73821536.
Stock Price History:
Over the past 52 weeks, ATHA has reached a high of $4.30, while it has fallen to a 52-week low of $0.46. The 50-Day Moving Average of the stock is -83.14%, while the 200-Day Moving Average is calculated to be -83.75%.
Shares Statistics:
It appears that ATHA traded 683.70K shares on average per day over the past three months and 1048740 shares per day over the past ten days. A total of 38.17M shares are outstanding, with a floating share count of 35.48M. Insiders hold about 7.69% of the company’s shares, while institutions hold 57.41% stake in the company. Shares short for ATHA as of 1724976000 were 992904 with a Short Ratio of 1.45, compared to 1722384000 on 989219. Therefore, it implies a Short% of Shares Outstanding of 992904 and a Short% of Float of 3.6700000000000004.
